Omicron Vaccine
- All
- News
- Videos
-
Covid-19 In India: LF.7 and NB.1.8.1, New Covid Variants Detected; Do You Need A Booster Dose?
The JN.1 variant and its related descendants belong to the Omicron family.
-
China's Wuhan Lab Creates New Vaccine For 'Future Pandemics': "Universal Protection"
Scientists at the institute have developed a new nanovaccine that shows promise in providing universal protection against all major Covid-19 variants.
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
India Records 5,880 Covid Cases In 24 Hours: Do Not Ignore These Symptoms Of The XBB.1.16 Variant
The new Covid-19 variant, XBB.1.16 is responsible for the surge in cases in India. According to the Health Ministry data, India has reported a total of 5,880 covid cases in the last 24 hours.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Up To 70% Of Those Under 19 Globally Susceptible To Covid: Study
Fifty to 70 per cent "children" below 19 years globally were susceptible to the SARS-CoV-2 infection by the end of 2021 and before the Omicron wave, showing a need for more effective vaccines and better vaccination coverage, according to a study.
-
Despite Vaccine Strides, India Opt Out Of Covid Shadow Yet
Just when the world was starting to believe that the novel coronavirus pandemic, the deadly new Omicron BF.7 strain reinforced the home truth that the world has certainly not seen the last of the pandemic.
-
Administering 220 Crore Doses Of Covid Vaccine In India Highpoint Of 2022
2022 saw a new wave of infections driven by the Omicron variant of coronavirus which ultimately subsided, putting India along with the world on the route to normalcy before fresh concerns arose amid rise in cases globally at the fag end of the year.
-
'Bivalent' Booster For Omicron, Original Covid Strain Approved By UK
The UK health authorities on Saturday approved a second "bivalent" vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19.
-
Adar Poonawalla Aims To Launch Omicron-Specific Covid Vaccine In 6 Months
The Serum Institute of India will try to launch Omicron-specific vaccine for COVID-19 after six months, its CEO Adar Poonawalla said on Thursday.
-
What You Need to Know About Moderna's New Vaccine For Omicron
Moderna Inc. has just received approval from the UK for a Covid-19 booster shot that targets omicron, the version of the virus that's now the world's most widespread.
-
Omicron-Specific Vaccine For India Coming Up: Adar Poonawalla To NDTV
The Serum Institute of India is working on an Omicron specific vaccine with Novavax, institute chief Adar Poonawalla told NDTV in an exclusive interview today. The vaccine can be expected by the year-end, he said.
-
UK Approves An Updated Moderna Vaccine Which Targets Omicron Variant
The UK's drug regulator said Monday it has approved an updated Moderna vaccine against the coronavirus that targets the Omicron variant as well as the original form.
-
New Omicron Sub-Variant In Delhi 20-30% More Infectious: Covid Panel Head
The strains of Omicron circulating in Delhi is more infectious than the base strain that surfaced in January this year and along with it, the effectiveness of the vaccines currently available has dropped 20 to 30 per cent,
-
US Medical Experts Call For Omicron-Specific Covid Boosters
A panel of US medical experts on Tuesday called for Omicron-specific boosters this fall, as anticipation mounts that Covid vaccines will be needed on an ongoing seasonal basis, as is the case for influenza.
-
Covid-19 In India: LF.7 and NB.1.8.1, New Covid Variants Detected; Do You Need A Booster Dose?
The JN.1 variant and its related descendants belong to the Omicron family.
-
China's Wuhan Lab Creates New Vaccine For 'Future Pandemics': "Universal Protection"
Scientists at the institute have developed a new nanovaccine that shows promise in providing universal protection against all major Covid-19 variants.
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
India Records 5,880 Covid Cases In 24 Hours: Do Not Ignore These Symptoms Of The XBB.1.16 Variant
The new Covid-19 variant, XBB.1.16 is responsible for the surge in cases in India. According to the Health Ministry data, India has reported a total of 5,880 covid cases in the last 24 hours.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Up To 70% Of Those Under 19 Globally Susceptible To Covid: Study
Fifty to 70 per cent "children" below 19 years globally were susceptible to the SARS-CoV-2 infection by the end of 2021 and before the Omicron wave, showing a need for more effective vaccines and better vaccination coverage, according to a study.
-
Despite Vaccine Strides, India Opt Out Of Covid Shadow Yet
Just when the world was starting to believe that the novel coronavirus pandemic, the deadly new Omicron BF.7 strain reinforced the home truth that the world has certainly not seen the last of the pandemic.
-
Administering 220 Crore Doses Of Covid Vaccine In India Highpoint Of 2022
2022 saw a new wave of infections driven by the Omicron variant of coronavirus which ultimately subsided, putting India along with the world on the route to normalcy before fresh concerns arose amid rise in cases globally at the fag end of the year.
-
'Bivalent' Booster For Omicron, Original Covid Strain Approved By UK
The UK health authorities on Saturday approved a second "bivalent" vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19.
-
Adar Poonawalla Aims To Launch Omicron-Specific Covid Vaccine In 6 Months
The Serum Institute of India will try to launch Omicron-specific vaccine for COVID-19 after six months, its CEO Adar Poonawalla said on Thursday.
-
What You Need to Know About Moderna's New Vaccine For Omicron
Moderna Inc. has just received approval from the UK for a Covid-19 booster shot that targets omicron, the version of the virus that's now the world's most widespread.
-
Omicron-Specific Vaccine For India Coming Up: Adar Poonawalla To NDTV
The Serum Institute of India is working on an Omicron specific vaccine with Novavax, institute chief Adar Poonawalla told NDTV in an exclusive interview today. The vaccine can be expected by the year-end, he said.
-
UK Approves An Updated Moderna Vaccine Which Targets Omicron Variant
The UK's drug regulator said Monday it has approved an updated Moderna vaccine against the coronavirus that targets the Omicron variant as well as the original form.
-
New Omicron Sub-Variant In Delhi 20-30% More Infectious: Covid Panel Head
The strains of Omicron circulating in Delhi is more infectious than the base strain that surfaced in January this year and along with it, the effectiveness of the vaccines currently available has dropped 20 to 30 per cent,
-
US Medical Experts Call For Omicron-Specific Covid Boosters
A panel of US medical experts on Tuesday called for Omicron-specific boosters this fall, as anticipation mounts that Covid vaccines will be needed on an ongoing seasonal basis, as is the case for influenza.
